These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [4.5 percent human albumin and polyvalent resuscitation. Initial evaluation after perfusion of 250 flasks]. Bourdais A; Lebris H; Mayère JP Dakar Med; 1982; 27(4):527-35. PubMed ID: 7184738 [No Abstract] [Full Text] [Related]
44. Are intravenous immunoglobulins really inappropriate in acquired von Willebrand syndrome? Federici AB; Rossi V; Sacchi E; Franchini M Blood Transfus; 2012 Jul; 10(3):402-3; author reply 404-5. PubMed ID: 22244008 [No Abstract] [Full Text] [Related]
45. [Mortality following administration of human albumin]. Gøtzsche PC Ugeskr Laeger; 2001 Apr; 163(16):2260-1. PubMed ID: 11344667 [No Abstract] [Full Text] [Related]
46. Repeated albumin infusions do not lower blood pressure in preeclampsia. Stratta P; Canavese C; Dogliani M; Gurioli L; Porcu MC; Todros T; Fianchino O; Benedetto C; Massobrio M; Balbi L Clin Nephrol; 1991 Nov; 36(5):234-9. PubMed ID: 1752073 [TBL] [Abstract][Full Text] [Related]
47. Aggravation of minimal change nephrotic syndrome by administration of human albumin. Yoshimura A; Ideura T; Iwasaki S; Taira T; Koshikawa S Clin Nephrol; 1992 Mar; 37(3):109-14. PubMed ID: 1563113 [TBL] [Abstract][Full Text] [Related]
48. Use and abuse of albumin in clinical practice. Soni N; Margarson M Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Dec; 34(12):784-8. PubMed ID: 10665319 [No Abstract] [Full Text] [Related]
49. How possibly are we to choose albumin or hydroxyethyl starch? Hanna BD Crit Care Med; 2009 Feb; 37(2):788-9. PubMed ID: 19325392 [No Abstract] [Full Text] [Related]
50. Health care personnel alerted to problems with lipid-based products, albumin. Am J Health Syst Pharm; 1998 Oct; 55(20):2078-9. PubMed ID: 9988565 [No Abstract] [Full Text] [Related]
51. Safety and efficacy of albumin administration in trauma. Chalidis B; Kanakaris N; Giannoudis PV Expert Opin Drug Saf; 2007 Jul; 6(4):407-15. PubMed ID: 17688384 [TBL] [Abstract][Full Text] [Related]
52. Albumin therapy in clinical practice. Mendez CM; McClain CJ; Marsano LS Nutr Clin Pract; 2005 Jun; 20(3):314-20. PubMed ID: 16207669 [TBL] [Abstract][Full Text] [Related]
53. The use of albumin in all patients with decompensated cirrhosis is not justified. Avidan B Isr Med Assoc J; 2005 Feb; 7(2):118-20. PubMed ID: 15729967 [No Abstract] [Full Text] [Related]
55. Concerning "human albumin administration in critically ill patients". Walder AD Intensive Care Med; 1999 Sep; 25(9):1033. PubMed ID: 10501771 [No Abstract] [Full Text] [Related]
56. Recommendations for the use of albumin and immunoglobulins. Liumbruno GM; Bennardello F; Lattanzio A; Piccoli P; Rossettias G; Blood Transfus; 2009 Jul; 7(3):216-34. PubMed ID: 19657486 [No Abstract] [Full Text] [Related]
57. [Treatment of cirrhotic complications with human serum albumin]. Henriksen JH; Ring-Larsen H Ugeskr Laeger; 2005 Jan; 167(4):414. PubMed ID: 15719571 [No Abstract] [Full Text] [Related]
58. The management of interstitial pulmonary edema. Significance of hypoproteinemia. Giordano JM; Joseph WL; Klingenmaier CH; Adkins PC J Thorac Cardiovasc Surg; 1972 Nov; 64(5):739-46. PubMed ID: 4563359 [No Abstract] [Full Text] [Related]
59. Induced plasma expander-like properties as a function of PEG-chains on extension arm facilitated PEGylation of albumin: "mushroom to brush-like" conformational transition of the PEG-albumin conjugate. Sahu RK; Nacharaju P; Manjula BN; Acharya SA Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(6):245-56. PubMed ID: 19922165 [TBL] [Abstract][Full Text] [Related]
60. Risk of immunologic reactions to human serum albumin solutions. Adamantos S; Chan DL; Goggs R; Humm K J Small Anim Pract; 2009 Apr; 50(4):206. PubMed ID: 19320816 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]